楼主: 美国国债423
258 0

[英文文献] Determinants of Pharmaceutical Innovation: The Role of Technological Opport... [推广有奖]

  • 0关注
  • 0粉丝

等待验证会员

学前班

0%

还不是VIP/贵宾

-

威望
0
论坛币
0 个
通用积分
0
学术水平
0 点
热心指数
0 点
信用等级
0 点
经验
10 点
帖子
0
精华
0
在线时间
0 小时
注册时间
2020-9-19
最后登录
2020-9-19

楼主
美国国债423 发表于 2005-1-7 10:58:04 |AI写论文

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
英文文献:Determinants of Pharmaceutical Innovation: The Role of Technological Opportunities Revisited
英文文献作者:Bastian Rake
英文文献摘要:
Recent empirical contributions emphasize the importance of (potential) market size for the development of new pharmaceuticals. At the same time many scholars point out the importance of of scientific advances for the industry’s R&D activities. Against this background I analyze the relationship between (potential) market size, technological opportunities, and the number of new pharmaceuticals in the United States. Technological opportunities are operationalized as growth rates of the relevant knowledge stock as proposed by Andersen (1999, 1998). I analyze a unique dataset by using an “entry stock” Poisson quasi-maximum likelihood estimator. The results reveal a rather robust and significantly positive response of the number of new pharmaceuticals, i.e., new molecular entities or new drug approvals, to market size and technological opportunities.
二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝


您需要登录后才可以回帖 登录 | 我要注册

本版微信群
扫码
拉您进交流群
GMT+8, 2026-1-29 08:49